Cellistic Logo
  • CDMO Services
    • Cell Line Development
    • Process Development
    • Analytical Development
    • Master Cell Banking
    • Tech Transfer
    • QC Testing
  • Platforms
    • Pulse™ Cell Line Development Platform
    • Cellistic's Echo™ Manufacturing Platform
      • Echo™-NK
      • Echo™-T
      • Echo™-Cardio
      • Echo™-Endothelial
  • GMP Manufacturing
  • Expert Insights
    • Announcements
    • Expert Opinion
    • Podcasts & Webinars
    • Posters
  • About
    • Team
    • Careers
    • Events
Contact
Cellistic Logo
  • CDMO Services
    • Cell Line Development
    • Process Development
    • Analytical Development
    • Master Cell Banking
    • Tech Transfer
    • QC Testing
  • Platforms
    • Pulse™ Cell Line Development Platform
    • Cellistic's Echo™ Manufacturing Platform
      • Echo™-NK
      • Echo™-T
      • Echo™-Cardio
      • Echo™-Endothelial
  • GMP Manufacturing
  • Expert Insights
    • Announcements
    • Expert Opinion
    • Podcasts & Webinars
    • Posters
  • About
    • Team
    • Careers
    • Events

Expert Opinion

All Announcements Events Expert Opinion Interviews Podcasts Posters Webinars
Scaling NK Cell manufacturing: From iPSCs to NK cells in a feeder-free, GMP-ready platform

April 16, 2025

Scaling NK Cell manufacturing: From iPSCs to NK cells in a feeder-free, ...

Natural Killer (NK) cell treatments are not readily accessible to patients due to persistent ...

Accelerating iPSC Allogeneic Cell Therapy Development: The Role of Allo Chassis™

March 27, 2025

Accelerating iPSC Allogeneic Cell Therapy Development: The Role of Allo ...

Introduction Cell therapies have surged to the forefront of modern medicine, primarily due to ...

GMP Principles in iPS Cell Line Development: A Key Foundation for Advancing Therapeutic Applications

February 17, 2025

GMP Principles in iPS Cell Line Development: A Key Foundation for ...

Introduction The manufacture of Advanced Therapy Medicinal Products (ATMPs) requires the ...

Gene-edited iPSC: the role of Automation in Cell Line Development

February 14, 2025

Gene-edited iPSC: the role of Automation in Cell Line Development

Precise gene editing is crucial for the development of cell-based therapies, particularly ...

iPSC-Derived Allogeneic Cell Therapies and Cloaking: Mechanisms, Importance and Strategies

February 5, 2025

iPSC-Derived Allogeneic Cell Therapies and Cloaking: Mechanisms, ...

Author: Suzanne Snellenberg, PhD - VP of Cell Line Development

Development and characterization of iPSC-derived regulatory T cells – Towards an allogenic cell therapy for the treatment of autoimmunity and inflammatory conditions

December 3, 2024

Development and characterization of iPSC-derived regulatory T cells – ...

Regulatory T cells (Tregs) play a pivotal role in maintaining immune homeostasis and ...

← 1 2 3 4 →
Cellistic Logo White
  • Services
  • Technologies
  • Cell Types
  • Facility
  • Resources
  • About
  • Contact
  • Team
  • Careers
x-twitter InBug-White-1

Rue Edouard Belin 2
1435 Mont-Saint-Guibert
Belgium

 

partnering@cellistic.com

  • Privacy Policy
  • Cookie Policy